Head-to-head · WeighScore
CoreAge Rx vs Wellorithm
By GLP-1 ScorecardUpdated
Score comparison
CoreAge Rx has the higher recorded score — 89.5/100 to 48.5/100.
CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
CoreAge Rx scores 89.5/100 (B+).
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | CoreAge Rx | Wellorithm |
|---|---|---|
| WeighScore | 89.5/100 | 48.5/100 |
| Grade | B+ | C |
| Site position | #1 | #527 |
| Semaglutide | Product page from $79/mo; navigation $99. Confirm selected quote. | $147 first payment; $247 ongoing for compounded injection. Pricing says monthly; terms say every 28 days. Initial consultation and shipping included; usable supply unconfirmed. |
| Tirzepatide | From $129/mo advertised; confirm selected charge, supply and renewal. | $249 first payment; $349 ongoing for compounded injection. Pricing says monthly; terms say every 28 days. Initial consultation and shipping included; usable supply unconfirmed. |
| Coverage | US only; therapy-specific state restrictions apply | Advertises all 50 states plus D.C.; confirm the specific treatment, prescribing clinician and dispensing pharmacy for your location. |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Not confirmed | Yes |
Site position #1 · B+
Strengths
- Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
- Advertises the same price across doses and no membership fee
- Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy
What to consider
- Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
- FAQ no-rebill and payment-timing statements differ from the subscription and order policy
- FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
- Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
- Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation
Site position #527 · C
Strengths
- Publishes first and ongoing compounded injection charges separately
- Advertises the same medication price across its listed weekly dose ranges
- Initial consultation and shipping included in injection plan cards
- Lists four branded options and a generic oral dissolving-tablet option; exact quote and prescription still needed
What to consider
- Pricing says monthly renewal, while terms say billing every 28 days
- Oral ingredient, strength, supply and price not specified in the public injection table
- Branded pages carry inconsistent three-month/500mg footnotes; insurance service and cash-only terms need reconciliation
- Treating Professional Entities and dispensing pharmacy unnamed in the reviewed policies
- Consultation fee retention on clinical rejection is not quantified; processed-payment refunds are restricted
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.